Injectable fluid silicone therapy. Human morbidity and mortality
- PMID: 1174244
Injectable fluid silicone therapy. Human morbidity and mortality
Abstract
Four patients who had received silicone injections had the following complications: migration, hepatic disease manifested as granulomatous hepatitis (previously undescribed, to our knowledge), hypopigmentation, and death. Silicone should now be considered as a possible cause of hepatic granulomas in an appropriate host.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
